NASDAQ:HALO

Halozyme Therapeutics Stock Predictions

etoro logo Buy HALO
*Your capital is at risk
$69.82
+3.54 (+5.34%)
At Close: Jun 03, 2026
Currently predicting for Thu, 4 Jun 2026

HALO Prediction Chart

HALO Predictions History

Latest community submissions for HALO.
Predictor Target Session Target Price Result Direction Accuracy Score
Sep 24, 2025 Bullish $75.64 X 0
Sep 24, 2025 $76.89 -0.88% $75.64 V 98.35% 1
Sep 24, 2025 $77.14 -0.55% $75.64 V 98.01% 1
Mar 19, 2025 Bullish $64.30 V 1
Mar 12, 2025 $60.78 -1.09% $60.89 V 99.82% 6
Mar 12, 2025 $61.03 -0.68% $60.89 V 99.76% 6
Mar 12, 2025 Bullish $60.89 X 0
Mar 11, 2025 $60.78 -1.08% $61.45 X 98.90% 1
Mar 11, 2025 $61.02 -0.68% $61.45 X 99.31% 3
Mar 11, 2025 Bullish $61.45 V 1
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for HALO with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT HALOZYME THERAPEUTICS
Halozyme Therapeutics
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable biologics, such as monoclonal antibodies and other therapeutic molecules, as well as small molecules a...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE